Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sigilon Therapeutics Inc.

    NASDAQ: SGTX · Real-Time Price · USD
    22.47
    -0.59 (-2.56%)
    At close: Aug 10, 2023, 10:00 PM

    Sigilon Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 19.62M 41.26M 42.07M 32.92M 34.55M 64.49M 107.14M 140.39M 162.41M 178.79M
    Short-Term Investments
    		 15.28M 15.11M 27.56M 45.34M 53.66M 38.62M 16.21M n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 1.04M 1.04M 1.03M 1.03M 1.03M 1.12M 1.12M 1.29M 1.29M 1.12M
    Receivables
    		 6.86M 4.96M 3.46M 23K 23K 62K 59K 27K 178K 140K
    Inventory
    		 250K 251K 250K n/a n/a 250K 250K 75K 75K 75K
    Other Current Assets
    		 2.86M 3.07M 1.08M 2.33M 3.94M 6.23M 2.73M 3.53M 3.61M 4.06M
    Total Current Assets
    		 44.87M 64.65M 74.41M 80.63M 92.17M 109.65M 126.39M 144.03M 166.27M 183.06M
    Property-Plant & Equipment
    		 9.65M 10.9M 11.83M 12.96M 14.22M 15.4M 16.86M 18.48M 18.56M 19.2M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 10.69M 11.94M 12.87M 13.99M 15.25M 16.52M 17.98M 19.77M 19.85M 20.32M
    Total Assets
    		 55.56M 76.59M 87.28M 94.62M 107.42M 126.17M 144.37M 163.8M 186.12M 203.38M
    Account Payables
    		 1.11M 1.33M 936K 1.41M 1.05M 2.04M 2.34M 3.23M 4.66M 2.01M
    Deferred Revenue
    		 13.78M 12.99M 12.88M 12.07M 16.32M 19.21M 17.03M 24.31M 25.96M 20.13M
    Short-Term Debt
    		 4.52M 11.16M 11.15M 11.13M 9.44M 7.74M 6.51M 5.67M 5.08M 5.43M
    Other Current Liabilities
    		 5.83M 3.51M 6.02M 5.95M 6.5M 8.06M 9M 7.66M 8.69M 6.91M
    Total Current Liabilities
    		 25.25M 28.99M 30.99M 30.55M 33.32M 37.05M 34.89M 40.87M 44.39M 34.48M
    Long-Term Debt
    		 2.87M 14.3M 16.91M 19.48M 22.01M 24.53M 26.99M 29.45M 30.22M 30.97M
    Other Long-Term Liabilities
    		 n/a n/a 233K 176K 281K n/a n/a 176K 176K 176K
    Total Long-Term Liabilities
    		 2.87M 14.3M 17.14M 19.65M 22.29M 24.53M 32.32M 29.63M 30.67M 39.87M
    Total Liabilities
    		 28.11M 43.29M 48.14M 50.21M 55.61M 61.58M 67.21M 70.49M 75.05M 74.35M
    Total Debt
    		 7.39M 25.47M 28.06M 30.61M 31.45M 32.27M 33.5M 35.12M 35.3M 36.4M
    Common Stock
    		 3K 32K 32K 32K 32K 32K 32K 32K 32K 32K
    Retained Earnings
    		 -271.68M -264.18M -256.8M -250.12M -241.44M -227.1M -213.24M -195.49M -175.34M -154.9M
    Comprehensive Income
    		 -177K -273K -429K -636K -556K -389K -10K n/a n/a n/a
    Shareholders Equity
    		 27.45M 33.29M 39.14M 44.41M 51.81M 64.59M 77.16M 93.3M 111.07M 129.03M
    Total Investments
    		 15.28M 15.11M 27.56M 45.34M 53.66M 38.62M 16.21M n/a n/a n/a

    Add to Watchlist